期刊文献+

缺血预处理在冠状动脉搭桥术中对心肌的保护作用 被引量:4

The protection of ischaemic preconditioning(IPC) on open heart surgery in CAD patients
下载PDF
导出
摘要 目的 :探讨缺血预处理 (Ischaemicpreconditioning ,IPC)在冠状动脉搭桥 (Coronaryarterydis ease ,CAD)手术中是否能有效的降低心肌细胞的损伤达到良好的心肌保护作用。方法 :将 2 4例均为三支病变、稳定心绞痛、首次进行搭桥患者随机分成 2组 :缺血预处理组 (I组 ) ;对照组 (C组 ) ;I组是于冷血停跳液诱导心脏停跳前给予心肌 2个循环的缺血 (2min)和再灌注 (3min) ;C组在应用冷血停跳液诱导心脏停跳前给予心脏并行辅助循环 10min ,术中每间隔 30min灌注一次心肌停搏液。在观察临床结果的同时 ,并于麻醉诱导后、术毕、术后 8~ 12h、2 4h、72h和 6d分别抽取静脉血测定血浆中肌酸激酶(CK MBmass)、肌钙蛋白I(TnI)的水平。结果 :在 2组中的术前及术后的临床指标没有明显差异。 1 I组的自动复跳率 (10 0 % )明显高于C组 (5 8% ) (P <0 0 5 ) ;2 cTNI和CK Mbmass的水平从术后 6h开始升高(P <0 0 5 ) ,在 2 4~ 72h达到峰值 ,在术后第 6d基本恢复。与C组比较I组在术后 6h、2 4h和 72h的血浆cTNI和CK Mbmass的水平明显降低 (P <0 0 1)。结论 :缺血预处理在心脏外科中的应用是安全的 ;同时通过监测肌钙蛋白I的释放 ,多次短时间的缺血预处理在低危冠状动脉搭桥患者中较常规方法更有利于缺血心肌的心肌保护? Objective: To investigate whether ischaemic preconditioning(IPC) could reduce myocardial injury and supply a good protection to the myocardium. Method: Twenty-four patients with three vessel coronary artery disease(CAD) and stable angina received for first time elective coronary artery bypass surgery were randomly divided into two groups:Group of ischaemic preconditioning(IPC) n =12;Group of control ( n =12).In group I the patients received two circles of ischemia(2 min) and reperfusion(3 min) before myocardium arrest induced by cool blood cardioplegia.Group C patients received routine method.Clinical outcomes was observed during operation and after operation.Blood sample was taken from venous at pre-bypass and post-bypass time to measure creatine kinase(CK-MBmass),troponin I(TnI).Result:In both groups,there were no differences regarding operative parameters.CK-Mbmass,cTnI release in group of control were higher than those in group I( P <0.01).Conclusion:The method of ishcaemic preconditioning is safe during heart surgery and has a good protection on open heart surgery in CABG.
出处 《心肺血管病杂志》 CAS 2004年第2期77-79,共3页 Journal of Cardiovascular and Pulmonary Diseases
关键词 缺血预处理 冠状动脉搭桥术 心肌保护 心肌缺血 再灌注损伤 Ischaemic preconditioning Coronary artery bypass graft Myocardial protection
  • 相关文献

参考文献5

  • 1Lawson CS,Downey JM.Preconditioning:state of the art myocardial protection.Cardiovasc Res,1993,27:542-551.
  • 2Murry CE,Jennings RB,Reimer KA.Preconditioning is ischaemia:a delay of lethal cell injury in ischaemia myocardium.Circulation,1986,74:1124-1136.
  • 3Yellon DM,Alkhulaifi AM,Pugsley WB.Preconditioning the human myocardium.Lancet,1993,342:276-277.
  • 4Jaquet L,Noirhomme P,Khouri G,et al.Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery.Eur J Cardiothorac Surg 1998,13:57-65.
  • 5Gottlieb RA,Groul DL,Zhu JY,et al.Preconditioning rabbits cardiomyocytes:role of ph,vascular proton ATP ase and apoptosis.J Clin Invest,1996,97:2391-2398.

同被引文献21

  • 1李军,秦建伟,梁永年,李芝,李琳.依达拉奉在联合瓣膜置换术中对心肌的保护作用[J].南京医科大学学报(自然科学版),2006,26(9):849-852. 被引量:12
  • 2Gerritsen WB,van Boven WJ,Boss DS,et al.Malondialdehyde in plasma,a biomarker of global oxidative stress during mini-CABG compared to on-and off-pump CABG surgery:a pilot study,Interaet Cardiovasc Thorac Stag,2006,5:27-31.
  • 3Vassiliades TA,Nielsen JL,Lonquist JL.Hemodynamic collapse during off-pump coronary artery bypass grafting.Ann Thorac Surg,2002,73:1874-1879.
  • 4Bufkin BL,Shearer ST,Vinten-Johansen J,et al.Preconditining during simulated MID CABG attenuates blood flow defects and neutrophil accumulation.Ann Thorac Surg,1998,66:726-732.
  • 5Thourani VH,Nakamura M,Duarte IG,et al.Ischemic Preconditioning attenuates postischemic coronary artery endothelial dysfunction in a model of minimally invasive direct coronary artery bypass.J Thorac Cardiovasc Surg,1999,117:383-389.
  • 6Murry CE,Jeunings RB,Beimer KA,et al.Preconditioning with ischemla:a delay of lethal cell injury in ischemic myocardium.Circulation,1986,74:1124-1136.
  • 7Fredhohn BB,Abbracchio MP,Burnstock G,et al.Nomenclature and classification of purinoceptors.Pharmacol Revs,1994,46:143-156.
  • 8Assail AR,Sdringola S,Ghani M,et al.Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no-reflow phenomenon".Catheter Cardiovasc interv,2000,51:27-31.
  • 9Barcin C,Denktas AE,Lennon RJ,et al.Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.Catheter Cardiovasc Interv,2004,61:484-491.
  • 10Casella G,Leibig M,Schiele TM,et al.Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractioual flow reserve.Am Heart J,2004,148:590-595.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部